首頁 > 市場調查報告書 > 醫療設備

整形外科齒科設備植牙關節移植

市場調查報告書

商品編碼

1758037

全球生物醫學植入市場

Biological Implants

出版日期: 2025年06月27日 | 出版商:

Global Industry Analysts, Inc. | 英文 281 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球生物醫學植入市場規模將達到 110 億美元

全球生物植入市場規模預計在2024年為86億美元，到2030年將達到110億美元，在2024-2030年的分析期間內，複合年成長率為4.2%。生物自體骨移植是本報告分析的細分市場之一，預計其複合年成長率為3.7%，到分析期結束時規模將達到63億美元。生物同種異體移植細分市場在分析期間的複合年成長率預計為4.8%。

美國市場規模估計為 23 億美元，中國市場預期複合年成長率為 6.6%

美國生物醫學植入市場規模預計2024年達到23億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到21億美元，在2024-2030年的分析期間內，複合年成長率為6.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.0%和4.3%。在歐洲，預計德國市場的複合年成長率為2.7%。

全球生物醫學植入市場—主要趨勢與促進因素摘要

為什麼植入將塑造再生醫學和外科手術的未來？

植入透過提供生物相容性解決方案，在各種臨床應用中促進自然癒合、組織整合和功能恢復，從而徹底改變了現代醫學。與金屬和塑膠製成的合成植入不同，植入由來自人體（自體移植或同種異體移植）或動物（異質骨移植）的天然組織製成，並經過精心設計，以確保生物相容性和無菌性，同時保留重要的生物結構。這些植入擴大用於整形外科、心血管外科、牙科、眼科和重組外科，因為它們能夠促進細胞增殖、減少免疫排斥並改善癒合效果。它們的普及也受到全球與老齡化相關的退化性疾病和創傷以及關節重建和器官重組等外科手術的增加的推動。例如，在整形外科手術中，生物支架和移植物可以取代或加固受損的韌帶、肌腱和軟骨，從而提供更自然的康復途徑並減少併發症。同樣，在心血管外科手術中，生物心臟瓣膜因其較低的血栓風險和終身抗凝血治療需求而比機械瓣膜更受青睞。患者對微創手術、更快的恢復時間和較低的長期異物反應發生率的偏好進一步推動了對生物植入的需求。隨著醫療保健向再生醫療和個人化醫療轉變，生物植入處於外科創新的前沿，改變了臨床醫生處理癒合和結構修復的方式。

科技創新如何提高生物醫學植入的性能和可靠性？

由於組織工程、材料科學和生物醫學技術的不斷進步，植入的性能和可靠性得到了顯著提升。去細胞技術更精準，能夠去除供體細胞內容物，同時保留支持宿主組織整合的細胞外基質。這項創新顯著降低了免疫抗原性，同時保持了承重和結構應用所需的機械完整性。此外，使用伽馬射線、超臨界二氧化碳和環氧乙烷的滅菌方法也得到了改進，以確保安全性，同時不劣化組織特性。包括3D生物列印在內的生物製造技術使得客製化植入支架成為可能，這些支架內嵌入的細胞和生長因子可根據患者的解剖結構和癒合需求進行客製化。奈米技術也促進了這一進步，奈米結構塗層和藥物傳輸系統被整合到植入中，能夠隨著時間的推移釋放抗生素、消炎藥和再生化合物。此外，研究人員正在開發複合植入，將天然組織與生物可吸收聚合物結合，以增強結構強度並調節分解速度。 MRI 和 CT 等影像技術的進步促進了術前規劃，並改善了植入與宿主組織的匹配，從而改善了手術效果並減少了術後併發症。數位健康工具和穿戴式裝置正與植入結合，即時監測其整合和癒合情況，從而催生了智慧植入系統。這些技術進步不僅提高了生物醫學植入的品質和安全性，也拓寬了其應用範圍，使其能夠應對複雜的醫療挑戰。

哪些醫療領域和全球地區正在快速採用生物植入？

植入在多個醫學學科中的應用激增，其中組織修復和生物相容性至關重要。整形外科仍然是主導領域，半月軟骨移植、骨移植和肌腱支架等植入用於修復運動傷害、骨折和退化性疾病。心血管醫學也是一個主要動力，生物心臟瓣膜、血管補片和心包組織被用於瓣膜修復和先天性缺陷的矯正。重組和整形外科嚴重依賴真皮基質和膠原蛋白支架來支持創傷、燒燙傷和整容手術後的組織再生。牙科手術使用生物膜和骨骼替代物進行牙周修復和植入固定。眼科和神經外科也正在結合生物材料來修復硬腦膜和眼組織，同時最大限度地降低排斥風險。按地區分類，北美憑藉高醫療支出、先進的外科基礎設施和優惠的報銷制度引領全球市場。美國尤其受益於其強大的移植網路和強力的監管框架，這些框架確保了安全和創新。歐洲緊隨其後，這得益於政府對再生醫學的支持以及領先生物技術公司的存在。亞太地區是成長最快的市場，這得益於中國、印度和日本等國家不斷增加的醫療保健投資、日益增強的醫療意識以及龐大的患者群體。拉丁美洲和中東是新興地區，醫療保健可近性的改善和醫療旅遊業的興起正在推動醫療需求。這些地區越來越重視以患者為中心和組織相容性的解決方案，這使得生物醫學植入成為優於傳統合成替代方案的首選方案。

推動全球生物醫學植入市場成長的因素有哪些？

全球生物醫學植入市場的成長受到多方面因素的驅動，包括醫療、技術、人口和政策。其中最重要的是骨關節炎、心血管疾病和糖尿病等慢性疾病在全球範圍內的負擔日益加重，這些疾病通常需要透過植入進行外科手術干預。人口老化，尤其是已開發國家和中等收入國家的人口老化也助長了需求的成長，因為老年患者更有可能接受關節關節重建、心臟瓣膜手術和組織重組手術。此外，微創和再生療法的趨勢正促使臨床醫生選擇生物相容性更高的植入，以促進自然癒合，同時減少手術創傷和恢復時間。生物工程、3D 生物列印和細胞療法等技術創新正在擴大可植入生物材料的範圍和功效。 FDA 和 EMA 等監管機構認知到生物製劑在滿足未滿足的臨床需求方面的潛力，正在簡化生物製藥的核准途徑。保險覆蓋和報銷模式也在不斷發展，以適應這些新的解決方案，尤其是在臨床證據不斷檢驗其長期安全性和有效性的情況下。此外，學術機構、生技新興企業和成熟醫療技術公司之間日益加強的合作，正在加速其研究、商業化和全球分銷。圍繞合成植入的環境和倫理問題也推動人們轉向生物分解性和生物衍生的替代品。這些因素共同使植入成為下一代醫學的關鍵組成部分，其功能的恢復不僅透過替換實現，還透過真正的生物整合和再生實現。

部分

產品（生物自體移植、生物同種異體移植、生物異質骨移植）；應用（心血管植入應用、整形外科植入應用、其他應用）

受訪公司範例（44家值得關注的公司）

Abbott Laboratories
AbbVie Inc.
Aroa Biosurgery
Baxter International Inc.
B. Braun Melsungen AG
Boston Scientific Corporation
CONMED Corporation
Cook Medical Inc.
Dentsply Sirona Inc.
Edwards Lifesciences Corporation
Globus Medical Inc.
Integra LifeSciences Holdings Corporation
Johnson & Johnson（DePuy Synthes）
LivaNova PLC
Mathys Ltd Bettlach
Medtronic plc
MicroPort Scientific Corporation
NuVasive Inc.
Smith & Nephew plc
Stryker Corporation

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

The global market for Biological Implants estimated at US$8.6 Billion in the year 2024, is expected to reach US$11.0 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Biological Autografts, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$6.3 Billion by the end of the analysis period. Growth in the Biological Allografts segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 6.6% CAGR

The Biological Implants market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Biological Implants Market - Key Trends & Drivers Summarized

Why Are Biological Implants Reshaping the Future of Regenerative Medicine and Surgical Interventions?

Biological implants are revolutionizing modern medicine by providing biologically compatible solutions that facilitate natural healing, tissue integration, and functional restoration in a variety of clinical applications. Unlike synthetic implants made from metals or plastics, biological implants are derived from natural tissues-either human (autografts or allografts) or animal (xenografts)-that are processed to ensure biocompatibility and sterility while retaining essential biological structures. These implants are increasingly used in orthopedic, cardiovascular, dental, ophthalmic, and reconstructive surgeries due to their ability to promote cellular growth, reduce immune rejection, and improve healing outcomes. Their widespread adoption is also being driven by the global increase in age-related degenerative diseases, trauma-related injuries, and surgical interventions such as joint replacements and organ reconstructions. For example, in orthopedic procedures, biological scaffolds and grafts are replacing or augmenting damaged ligaments, tendons, and cartilage with more natural recovery paths and fewer complications. Similarly, in cardiovascular surgery, biological heart valves are favored over mechanical alternatives for their lower thrombogenic risk and reduced need for lifelong anticoagulation therapy. The demand for biologically derived implants is further amplified by patient preference for minimally invasive procedures, faster recovery times, and lower incidences of long-term foreign body reactions. As healthcare shifts towards regenerative and personalized medicine, biological implants stand at the forefront of surgical innovation-transforming the way clinicians approach healing and structural repair.

How Are Technological Innovations Enhancing the Performance and Reliability of Biological Implants?

The performance and reliability of biological implants have been significantly improved by ongoing advancements in tissue engineering, material science, and biomedical technologies. Decellularization techniques have become more precise, allowing the removal of donor cellular content while preserving the extracellular matrix that supports host tissue integration. This innovation greatly reduces immunogenicity while maintaining the mechanical integrity necessary for load-bearing or structural applications. Furthermore, sterilization methods using gamma irradiation, supercritical CO2, and ethylene oxide are now refined to ensure safety without degrading tissue properties. Biofabrication technologies, including 3D bioprinting, have enabled the creation of customized implantable scaffolds embedded with cells and growth factors tailored to the patient’s anatomy and healing requirements. Nanotechnology is also contributing to this progress, with nanostructured coatings and drug delivery systems being integrated into biological implants to release antibiotics, anti-inflammatory agents, or regenerative compounds over time. Additionally, researchers are developing composite biological implants that combine natural tissues with bioresorbable polymers to enhance structural strength and tailor degradation rates. Improvements in imaging technologies like MRI and CT have facilitated preoperative planning and better matching of implants with host tissue, improving surgical outcomes and reducing postoperative complications. Digital health tools and wearables are starting to be paired with implants to monitor integration and healing in real time, marking the beginning of smart implant systems. Together, these technological advancements are not only improving the quality and safety of biological implants but are also broadening their applicability across complex medical challenges.

Which Medical Fields and Global Regions Are Leading the Surge in Biological Implant Adoption?

The adoption of biological implants is surging across multiple medical fields where tissue restoration and biocompatibility are paramount. Orthopedics remains a dominant sector, where implants like meniscal allografts, bone grafts, and tendon scaffolds are used to repair sports injuries, fractures, and degenerative conditions. Cardiovascular medicine is another major driver, particularly in the use of bioprosthetic heart valves, vascular patches, and pericardial tissues for valve repair and congenital defect correction. Reconstructive and plastic surgery heavily relies on dermal matrices and collagen scaffolds to support tissue regeneration following trauma, burns, or cosmetic enhancements. In dental surgery, biological membranes and bone substitutes are used for periodontal repairs and implant anchoring. Ophthalmology and neurosurgery are also integrating biologically based materials to repair dura mater or ocular tissues with minimal rejection risk. Regionally, North America leads the global market due to high healthcare expenditure, advanced surgical infrastructure, and favorable reimbursement systems. The United States, in particular, benefits from a robust transplant network and strong regulatory frameworks that ensure safety and innovation. Europe follows closely, driven by government support for regenerative medicine and the presence of leading biotech firms. Asia-Pacific is the fastest-growing market, fueled by rising healthcare investments, increasing awareness, and a large patient base in countries like China, India, and Japan. Latin America and the Middle East are emerging regions where improvements in healthcare access and the rise of medical tourism are boosting demand. Across these varied geographies, the increasing focus on patient-centric, tissue-compatible solutions is making biological implants a preferred choice over traditional synthetic options.

What Is Fueling the Growth in the Global Biological Implants Market?

The growth in the global biological implants market is driven by a multifaceted combination of medical, technological, demographic, and policy-related factors that are collectively reshaping surgical care. Foremost among these is the rising global burden of chronic diseases, such as osteoarthritis, cardiovascular disorders, and diabetes, which frequently necessitate implant-based surgical interventions. The growing aging population, particularly in developed and middle-income countries, also contributes to increased demand, as elderly patients are more likely to undergo joint replacements, valve surgeries, and tissue reconstruction procedures. Moreover, the trend toward minimally invasive and regenerative treatments is pushing clinicians to choose biologically compatible implants that promote natural healing while reducing surgical trauma and recovery times. Technological innovation, including advancements in bioengineering, 3D bioprinting, and cellular therapies, is expanding the range and effectiveness of implantable biological materials. Regulatory bodies such as the FDA and EMA are streamlining approval pathways for biologics, recognizing their potential to address unmet clinical needs. Insurance coverage and reimbursement models are also evolving to accommodate these newer solutions, particularly as clinical evidence continues to validate their long-term safety and efficacy. Furthermore, increasing collaboration between academic institutions, biotech startups, and established medtech companies is accelerating research, commercialization, and global distribution. Environmental and ethical concerns around synthetic implants are also prompting a shift toward biodegradable and biologically derived alternatives. Collectively, these drivers are positioning biological implants as a critical component of next-generation medical care, where restoration of function is achieved not through replacement alone, but through true biological integration and regeneration.

SCOPE OF STUDY:

The report analyzes the Biological Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Biological Autografts, Biological Allografts, Biological Xenografts); Application (Cardiovascular Implants Application, Orthopedic Implants Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

Abbott Laboratories
AbbVie Inc.
Aroa Biosurgery
Baxter International Inc.
B. Braun Melsungen AG
Boston Scientific Corporation
CONMED Corporation
Cook Medical Inc.
Dentsply Sirona Inc.
Edwards Lifesciences Corporation
Globus Medical Inc.
Integra LifeSciences Holdings Corporation
Johnson & Johnson (DePuy Synthes)
LivaNova PLC
Mathys Ltd Bettlach
Medtronic plc
MicroPort Scientific Corporation
NuVasive Inc.
Smith & Nephew plc
Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Tariff Impact on Global Supply Chain Patterns
- Biological Implants - Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Prevalence of Chronic Diseases and Organ Failures Throws the Spotlight on Biological Implants
- Advancements in Regenerative Medicine Spur Growth in Bioengineered and Cell-Based Implant Technologies
- Here's How Aging Populations Are Expanding the Addressable Market for Cardiovascular and Orthopedic Implants
- Increased Adoption of Xenografts and Allografts Strengthens the Business Case for Biologic Materials
- Minimally Invasive Surgical Trends Drive Demand for Bio-Compatible and Resorbable Implant Solutions
- Tissue Engineering Innovations Enhance Functional Integration and Longevity of Biological Implants
- Global Growth in Organ Transplants and Reconstructive Surgeries Fuels Use of Soft Tissue Biological Scaffolds
- Here's the Story: How 3D Bioprinting Is Creating Future Opportunities in Patient-Specific Biological Implants
- Integration with Smart and Drug-Eluting Technologies Propels Next-Generation Implant Development
- Rising Focus on Post-Surgical Healing and Biocompatibility Fuels Demand for Naturally Derived Implant Materials
- Expansion of Biologic Mesh Use in Hernia and Pelvic Floor Repairs Drives Institutional Procurement
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Biological Implants Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 3: World Historic Review for Biological Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 4: World 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Biological Autografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 6: World Historic Review for Biological Autografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 7: World 16-Year Perspective for Biological Autografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Biological Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 9: World Historic Review for Biological Allografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 10: World 16-Year Perspective for Biological Allografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Biological Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 12: World Historic Review for Biological Xenografts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 13: World 16-Year Perspective for Biological Xenografts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 15: World Historic Review for Cardiovascular Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 16: World 16-Year Perspective for Cardiovascular Implants Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Orthopedic Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 18: World Historic Review for Orthopedic Implants Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 19: World 16-Year Perspective for Orthopedic Implants Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 23: USA Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 25: USA 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 26: USA Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 27: USA Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 28: USA 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
CANADA
- TABLE 29: Canada Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 30: Canada Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 31: Canada 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 32: Canada Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 33: Canada Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 34: Canada 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
JAPAN
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 35: Japan Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 36: Japan Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 37: Japan 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 38: Japan Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 39: Japan Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 40: Japan 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
CHINA
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 41: China Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 42: China Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 43: China 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 44: China Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 45: China Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 46: China 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
EUROPE
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 47: Europe Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Biological Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
- TABLE 50: Europe Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 52: Europe 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 53: Europe Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 54: Europe Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 55: Europe 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
FRANCE
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 56: France Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 57: France Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 58: France 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 59: France Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 60: France Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 61: France 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
GERMANY
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 62: Germany Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 63: Germany Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 64: Germany 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 65: Germany Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 66: Germany Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 67: Germany 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
ITALY
- TABLE 68: Italy Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 69: Italy Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 70: Italy 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 71: Italy Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 72: Italy Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 73: Italy 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
UNITED KINGDOM
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 74: UK Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 75: UK Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 76: UK 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 77: UK Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 78: UK Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 79: UK 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
SPAIN
- TABLE 80: Spain Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 81: Spain Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 82: Spain 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 83: Spain Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 84: Spain Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 85: Spain 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
RUSSIA
- TABLE 86: Russia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 87: Russia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 88: Russia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 89: Russia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 90: Russia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 91: Russia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
REST OF EUROPE
- TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 93: Rest of Europe Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 94: Rest of Europe 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 96: Rest of Europe Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 97: Rest of Europe 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
ASIA-PACIFIC
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 99: Asia-Pacific Historic Review for Biological Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 100: Asia-Pacific 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
- TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 102: Asia-Pacific Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 103: Asia-Pacific 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 105: Asia-Pacific Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 106: Asia-Pacific 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
AUSTRALIA
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 107: Australia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 108: Australia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 109: Australia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 110: Australia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 111: Australia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 112: Australia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
INDIA
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 113: India Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 114: India Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 115: India 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 116: India Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 117: India Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 118: India 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
SOUTH KOREA
- TABLE 119: South Korea Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 120: South Korea Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 121: South Korea 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 122: South Korea Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 123: South Korea Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 124: South Korea 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
REST OF ASIA-PACIFIC
- TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 126: Rest of Asia-Pacific Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 129: Rest of Asia-Pacific Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
LATIN AMERICA
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 131: Latin America Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 132: Latin America Historic Review for Biological Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 133: Latin America 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
- TABLE 134: Latin America Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 135: Latin America Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 136: Latin America 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 137: Latin America Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 138: Latin America Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 139: Latin America 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
ARGENTINA
- TABLE 140: Argentina Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 141: Argentina Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 142: Argentina 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 143: Argentina Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 144: Argentina Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 145: Argentina 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
BRAZIL
- TABLE 146: Brazil Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 147: Brazil Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 148: Brazil 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 149: Brazil Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 150: Brazil Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 151: Brazil 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
MEXICO
- TABLE 152: Mexico Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 153: Mexico Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 154: Mexico 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 155: Mexico Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 156: Mexico Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 157: Mexico 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
REST OF LATIN AMERICA
- TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 159: Rest of Latin America Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 160: Rest of Latin America 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 162: Rest of Latin America Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 163: Rest of Latin America 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
MIDDLE EAST
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 164: Middle East Recent Past, Current & Future Analysis for Biological Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
- TABLE 165: Middle East Historic Review for Biological Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 166: Middle East 16-Year Perspective for Biological Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
- TABLE 167: Middle East Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 168: Middle East Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 169: Middle East 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 170: Middle East Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 171: Middle East Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 172: Middle East 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
IRAN
- TABLE 173: Iran Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 174: Iran Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 175: Iran 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 176: Iran Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 177: Iran Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 178: Iran 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
ISRAEL
- TABLE 179: Israel Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 180: Israel Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 181: Israel 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 182: Israel Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 183: Israel Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 184: Israel 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
SAUDI ARABIA
- TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 186: Saudi Arabia Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 187: Saudi Arabia 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 189: Saudi Arabia Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 190: Saudi Arabia 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
UNITED ARAB EMIRATES
- TABLE 191: UAE Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 192: UAE Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 193: UAE 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 194: UAE Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 195: UAE Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 196: UAE 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
REST OF MIDDLE EAST
- TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 198: Rest of Middle East Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 199: Rest of Middle East 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 201: Rest of Middle East Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 202: Rest of Middle East 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030
AFRICA
- Biological Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 203: Africa Recent Past, Current & Future Analysis for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 204: Africa Historic Review for Biological Implants by Product - Biological Autografts, Biological Allografts and Biological Xenografts Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 205: Africa 16-Year Perspective for Biological Implants by Product - Percentage Breakdown of Value Sales for Biological Autografts, Biological Allografts and Biological Xenografts for the Years 2014, 2025 & 2030
- TABLE 206: Africa Recent Past, Current & Future Analysis for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
- TABLE 207: Africa Historic Review for Biological Implants by Application - Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
- TABLE 208: Africa 16-Year Perspective for Biological Implants by Application - Percentage Breakdown of Value Sales for Cardiovascular Implants Application, Orthopedic Implants Application and Other Applications for the Years 2014, 2025 & 2030